SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eightco Holdings, Inc. is a publicly traded holding company, which operates in the consumer products and e-commerce markets, focusing on developing and deploying innovative technology, and capital solutions to empower small to medium-sized businesses. It operates through the North America and Europe geographical segments. The company was founded in 1966 and is headquartered in Easton, PA.

Eightco Holdings Inc

Eightco Holdings ($OCTO) is trending due to a significant private placement announcement and a strategic investment related to launching a Worldcoin treasury strategy, sparking a massive pre-market surge and short squeeze. The community is actively discussing the potential for further gains, with some drawing comparisons to other high-flying stocks and speculating on how high it can go, while others caution about potential dilution risks. News of Dan Ives joining as Chairman seems to be adding fuel to the fire.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending after a live demo of its solid-state batteries powering a Ducati motorcycle at the IAA Mobility event, sparking enthusiasm among investors. The community is buzzing about the potential for the technology in EVs and motorcycles, along with possible partnerships with major automotive manufacturers. Despite a long timeline to commercialization, some believe the demonstration validates the long-term potential of solid-state battery technology.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

ASTS is trending due to a mix of factors, including recent news of SpaceX acquiring spectrum, sparking concerns about increased competition, and the overall volatility in space stocks. The community is debating whether this validates ASTS's technology or poses a significant challenge. Bullish investors view it as a buying opportunity, while bears express concerns about dilution and the company's ability to compete.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as the community discusses its potential S&P 500 inclusion, with many anticipating increased exposure and fund buying. Bullish sentiment is fueled by positive analyst ratings and discussions around the company's AI-driven ad platform, though some traders express caution about valuation and potential pullbacks.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as it joins the S&P 500, replacing Caesars Entertainment, which has sparked enthusiasm and predictions of significant inflows from index funds. While some traders are wary of a potential "sell the news" event, others anticipate further gains fueled by the upcoming company summit and potential rate cuts. Community members are actively discussing potential price targets and the impact of index inclusion on the stock's long-term value.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs ($PL) is trending due to strong Q2 FY2026 earnings, including record revenue and positive adjusted EBITDA, leading to raised full-year guidance. The community is actively discussing the significant increase in backlog and remaining performance obligations, viewing it as a sign of strong sales execution. Despite the positive news, some traders are questioning why the stock is not performing better, while others are optimistic about a potential rerating and further gains.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is trending as the stock hits new 52-week lows, sparking discussions about potential support levels and whether it's a buying opportunity or a sign of further decline. The community is debating factors like weak traffic, competition from CAVA, and concerns about the CEO's strategy, with some calling for a focus on value and portion sizes. Some analysts suggest the stock is oversold and poised for a rebound, while others express skepticism about its premium valuation amid slowing growth.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar ($GSAT) is trending amid community excitement surrounding the potential valuation of its spectrum assets, drawing comparisons to recent deals made by competitors like EchoStar. Speculation is increasing about potential acquisitions, partnerships with major players like Apple, Verizon, or SpaceX, and the impact of upcoming catalysts such as India spectrum approval and news from the Apple event.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors anticipate upcoming earnings, with community chatter focused on potential profitability and the impact of new ventures like trading cards. Some traders express frustration with the stock's sideways movement, while others debate whether to expect a pre-earnings run-up or a post-earnings dump. The stock is also being compared to other meme stocks and those with short squeezes.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics (MCRB) is trending amid rumors of a potential acquisition by Nestle, with community members closely watching for confirmation and speculating on the details of the offer, including milestone payments. The company's conference presentation is also generating buzz, as investors hope for updates on potential deals. A potential short squeeze is also part of the discussion due to the ticker's high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug-Candidates

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and...

Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 HARMONIC Clinical Trial of LP-300 in Never-Smoker NSCLC Patients

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted cancer therapies using its proprietary RADR AI platform, today announced that the first patient has...

Lantern Pharma and Starlight Therapeutics Present LP-184 (STAR-001) Phase 1b Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (SNO) 2024 Highlighting Novel Synthetic Lethality

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence company transforming oncology drug development, and its wholly-owned subsidiary Starlight Therapeutics, focused exclusively on CNS and...

Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC Clinical Trial of LP-300 in Never-Smoker NSCLC Patients

Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform...

Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board

Starlight Therapeutics, a wholly-owned subsidiary of Lantern Pharmaceuticals (NASDAQ: LTRN), formed to develop transformative CNS cancer treatments with AI-powered innovation, announced today the...

Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024

Lantern Pharma to Host & Participate in Two Public Webinars During October

Lantern Pharmas Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.

Current Price	$4.23
Prev Close	$4.31
Open	$4.38
Dividend Yield	0.00%
50-Day Moving Average	$4.13
Beta	1.22
Avg. Volume	132,791.52
PE Ratio	-2.41

52-Week High	$6.12
52-Week Low	$2.55
Market Capitalization	$46.55M
EPS (Annual)	-$1.93
Price to Book	3.71
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

LTRN
Lantern Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LTRN News

LTRN Lantern Pharma Inc